Altered expression of transforming growth factor-βs in chronic renal rejection

Kidney International

Volumn 50, Issue 2, 1996, Pages 489-498

  Horvath, Laszlo Zs ^b   Friess, Helmut ^b   Schilling, Martin ^a   Borisch, Bettina ^b   Deflorin, Judith ^b   Gold, Leslie I ^b   Korc, Murray ^b   Büchler, Markus W ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY ALLOGRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL;

EID: 0029789045     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.340     Document Type: Article

References (51)

1. MASON D: The role of T cell subpopulation in allograft rejection. Transplant Proc 20:239-242, 1988
2. KEHR JH, WAKEFIELD LM, ROBERTS AB, JAKOWLEW S, ALVAREZMON M, DERYNCK R, SPORN MB, FAUCI AS: Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T-cell growth. J Exp Med 163:1037-1050, 1986
3. DUBOIS C, RUSCETTI F, PALASZYNSKI E, FALK L, OPPENHEIM J, KELLER J: Down modulation of the interleukin-1 receptor by transforming growth factor-β: Produced mechanism of inhibition of IL-1 action. J Exp Med 172:737, 1990
4. ROBERTS AB, SPORN MB: The transforming growth factor-βs, in Peptide growth factors and their receptors, in Handbook of Experimental Pharmacology (vol 95), edited by SPORN MB, ROBERTS AB, Heidelberg, Springer, 1990, pp 419-472
5. DERYNCK R, LINDOUIST PB, LEE A, WEN D, TAMM J, GRAYCAR JL, RHEE L, MASON AJ, MILLER DA, COFFEY RJ, MOSES HL, CHEN EY: A new type of transforming growth factor-β, TGF-β3. EMBO J 6:1633-1636, 1987
6. WAHL SM, MCCARTNEY-FRANCIS N, MERGENHAGEN SE: Inflammatory and immunomodulatory roles of TGF-β. (abstract) Immunol Today 10:258, 1989
7. KEHRL JH: Transforming growth factor-β: An important mediator of immunoregulation. Int J Cell Cloning 9:438, 1991
8. RUSCETTI FW, PALLADINO MA: Transforming growth factor-β and the immune system. Prog Growth Factor Res 3:159, 1991
9. FRIESS H, YAMANAKA Y, BÜCHLER M, EBERT M, BEGER HG, GOLD LI, KORC M: Enhanced expression of transforming growth factor-beta isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology 105:1846-1856, 1993
10. FRIESS H, YAMANAKA Y, BÜCHLER M, BEGER HG, KOBRIN MS, BALDWIN RL, KORC M: Enhanced expression of the type II transforming growth factor-beta receptor in human pancreatic cancer cells without alteration of type III receptor expression. Cancer Res 53: 2704-2707, 1993
11. BORDER WA, NOBLE N: Transforming growth factor beta in tissue fibrosis. N Engl J Med 331:1286-1292, 1994
12. BORDER WA, NOBLE NA, YAMAMOTO T, HARPER JR, YAMAGUCHI YU, PIERSCHBACHER MD, ROUSLAHTI E: Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature 360:361-364, 1992
13. JAKOWLEW SB, DILLARD PJ, SPORN MB, ROBERTS AB: Complementary deoxyribonucleic acid encoding transforming growth factor-β4 from chicken embryo chondrocytes. Mol Endocrinol 2:1186-1195, 1988
14. KONDAIAH P, SANDS MJ, SMITH JM, FIELDS A, ROBERTS AB, SPORN MB, MELTON DA: Identification of a novel transforming growth factor-β (TGF-β5) mRNA in Xenopus laevis. J Biol Chem 265:1089-1093, 1990
15. LIN HY, WANG X-F, NG-EATON E, WEINBERG RA, LODISH HF: Expression cloning of the TGF-beta type II receptor, a functional transmembrane serine/threonine kinase. Cell 68:775-785, 1992
16. WRANA JL, ATTISANO L, CARCAMO J, ZENTELLA A, DOODY J, LAIHO M, WANG X-F, MASSAGUE J: TGF beta signals through a heteromeric protein kinase receptor complex. Cell 71:1003-1014, 1992
17. MASSAGUE J: The transforming growth factor-β family. Annu Rev Cell Biol 6:597-641, 1990
18. SPORN MB, ROBERTS AB: Transforming growth factor-β: Recent progress and new challenges. J Cell Biol 119:1017-1021, 1992
19. MASSAGUE J: Receptors for the TGF-beta family. Cell 69:1067-1070, 1992
20. LOPEZ-CASILLAS F, CHEIFETZ S, DOODY J, ANDRES JL, LANE WS, MASSAGUE J: Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-β receptor system. Cell 67:785-795, 1991
21. WANG X-F, LIN HY, NG-EATON E, DOWNWARD J, LODISH HF, WEINBERG RA: Expression cloning and characterization of the TGF-beta type III receptor. Cell 67:797-805, 1991
22. ZHAO XM, FRIST WH, YEOH TK, MILLER GG: Expression of cytokine genes in human cardiac allografts: Correlation of IL-6 and transforming growth factor-beta (TGF-β) with histological rejection. Clin Exp Immunol 93:448-451, 1993
23. ZHAO XM, YEOH TK, HIEBERT M, FRIST WH, MILLER GG: The expression of acidic fibroblast growth factor (heparin-binding growth factor-1) and cytokine genes in human cardiac allografts and T cells. Transplantation 56:1177-1182, 1993
24. LASS JH, MUSCH DC, GORDON JF, LAING RA: Epidermal growth factor and insulin use in corneal preservation. Results of a multicenter trial. The Corneal Preservation Study Group Ophthalmology 101:352-359, 1994
25. GILL RG: Transforming growth factor β prevents islet allograft rejection. Transplant Proc 23:747-748, 1991
26. CAREL JC, SHEEHAN KC, SCHREIBER RD, LACY PE: Prevention of rejection of transforming growth factor beta-treated rat-to-mouse islet xenografts by monoclonal antibody to tumor necrosis factor. Transplantation 55:456-458, 1993
27. BISHOP GA, MATSUMOTO GW, MCCAUGHAN, KENNEY JS: Identification of cytokine protein expression in human liver allograft rejection: Methods development and expression of IL-1β, IL-6, IFN-γ, and basic fibroblast growth factor. Transplant Proc 24:2310-2312, 1992
28. HAYRY P, RÄISÄNEN A, USTINOV J, MENNANDER A, PAAVONEN T: Somatostatin analog Lanreotide inhibits myocyte replication and several growth factors in allograft arteriosclerosis. FASEB J 7:1055-1060, 1993
29. WALTENBERGER J, WANDERS A, FELLSTRÖM B, MIYAZONO K, HELDIN C-H, FUNA K: Induction of transforming growth factor-β during cardiac allograft rejection. J Immunol 151:1147-1157, 1993
30. HIGGY N, DAVIDOFF H, BENEDIKTSSON H, PAUL LC: Platelet-derived growth factor receptor expression in chronic rejection of cardiac and renal grafts in the rat. Transplant Proc 23:609-610, 1991
31. SHADDY RE, HANSEN JC, COWLEY CG: Effects of T cells on platelet-derived growth factor-like protein secretion from endothelial cells. J Heart Lung Trans 11:48-57, 1992
32. STEIN-OAKLEY AN, TZANIDIS A, FULLER PJ, JABLONSKI P, THOMPSON NM: Chronic renal allograft rejection: Altered distribution and reduced expression of epidermal growth factor in a rat model. Transplant Proc 25:2902-2903, 1993
33. JACOB C, MAACHI F, EL FARRICHA O, DOUSSET B, KESSLER M, BELLEVILLE F, NABET P: Role of the kidney in the expression of low molecular weight factors with growth factor activity. Clin Nephrol 39:327-334, 1993
34. SHIHAB FS, YAMAMOTO T, NAST CC, COHEN AH, NOBLE NA, GOLD LI, BORDER WA: Transforming growth factor-β and matrix protein expression in acute and chronic rejection of human renal allografts. J Am Soc Nephrol 6:286-294, 1995
35. YAMANAKA Y, FRIESS H, BÜCHLER M, BEGER HG, GOLD LI, KORC M: Synthesis and expression of transforming growth factor-beta1, beta2, and beta3 in the endocrine and exocrine pancreas. Diabetes 42:746-756, 1993
36. PELTON RW, SAXENA B, JONES M, MOSES HL, GOLD LI: Immunohistochemical localization of TGF-β1, TGF-β2, and TGF-β3 in the mouse embryo; Expression patterns suggest multiple roles during embryonic development. J Cell Biol 115:1091-1105, 1991
37. MCMULLEN H, LONGAKER MT, CABERA RC, SUNG JJ, CANETE J, SIEBERT JW, LORENZ HP, GOLD LI: Analysis of TGF-β1, TGF-β2, and TGF-β3 immunoreactivity during ovine wound repair. Wound Repair Regen 3:141-156, 1995
38. DERYNCK R, JARRETT JA, CHEN EY, EATON DH, BELL JR, ASSOIAN RK, ROBERTS AB, SPORN MB, GOEDDEL DV: Human transforming growth factor-β complementary sequence and expression in normal and transformed cells. Nature (Lond) 316:701-705, 1985
39. ARRICK BA, KORC M, DERYNCK R: Differential regulation of expression of three transforming growth factor-β species in human breast cancer cell lines by estradiol. Cancer Res 50:299-303, 1990
40. KORC M, CHANDRASEKAR B, YAMANAKA Y, FRIESS H, BÜ:CHLER M, BEGER HG: Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increase in the levels of epidermal growth factor and transforming growth factor alpha. J Clin Invest 90:1352-1360, 1992
41. BALDWIN RL, KORC M: Growth inhibition of human pancreatic carcinoma cells by transforming growth factor beta-1. Growth Factors 8:23-34, 1993
42. BALMAIN A, KRUMLAUF R, VASS JK, BIRNIE GD: Cloning and characterization of the abundant cytoplasmic 7S RNA from mouse cells. Nucl Acids Res 10:4259-4277, 1982
43. FEINBERG AP, VOGELSTEIN B: A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6-13, 1983
44. CHOMCZYNSKI P, SACCHI N: Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
45. KORC M, OWERBACH D, QUINTO C, RUTTER WJ: Pancreatic isletacinar cell interaction: Amylase messenger RNA levels are determined by insulin. Science 213:351-353, 1981
46. SIEGEL S: Nonparametric Statistics for Behavioral Sciences. New York, McGraw-Hill Book Co., 1956
47. NAKAMURA T, MILLER D, ROUSHLAHTI E, BORDER WA: Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-β1. Kidney Int 41:1213-1221, 1992
48. YAMAMOTO T, NOBLE NA, MILLER DE, BORDER WA: Sustained expression of TGF-beta 1 underlies development of progressive kidney fibrosis. Kidney Int 55:916-927, 1994
49. WALLICK SC, FIGARI IS, MORRIS RE, LEVINSON AD, PALLADINO MA: Immunoregulatory role of transforming growth factor-β (TGF-β) in development of killer cells: Comparison of active and latent TGF-β1. (abstract) J Exp Med 172:1777, 1990
50. BRANDES ME, ALLEN JB, OGAWA Y, WAHL SM: Transforming growth factor-β1 suppresses acute and chronic arthritis in experimental animals. (abstract) J Clin Invest 87:1108, 1991
51. JOHNS LD, FLANDERS KC, RANGES GE, SRIRAM S: Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-β1. (abstract) J Immunol 147:1792, 1991